Longevity and Anti-senescence Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: L4B80382CB04EN
Market Monitor Global

Abstracts

Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.

This report contains market size and forecasts of Longevity and Anti-senescence Therapy in Global, including the following market information:

Global Longevity and Anti-senescence Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Longevity and Anti-senescence Therapy market was valued at 327.6 million in 2021 and is projected to reach US$ 552.4 million by 2028, at a CAGR of 7.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemolytic Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Longevity and Anti-senescence Therapy include CohBar, TA Sciences, Unity Biotechnology, AgeX Therapeutics?Inc and PowerVision Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Longevity and Anti-senescence Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Longevity and Anti-senescence Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Longevity and Anti-senescence Therapy Market Segment Percentages, by Type, 2021 (%)

• Hemolytic Drug Therapy
• Gene Therapy
• Immunotherapy
• Other Stem Cell Therapies

Global Longevity and Anti-senescence Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Longevity and Anti-senescence Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Service Institution
• Drug and Device Sales

Global Longevity and Anti-senescence Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Longevity and Anti-senescence Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Longevity and Anti-senescence Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Longevity and Anti-senescence Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CohBar
• TA Sciences
• Unity Biotechnology
• AgeX Therapeutics?Inc
• PowerVision Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Longevity and Anti-senescence Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Longevity and Anti-senescence Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LONGEVITY AND ANTI-SENESCENCE THERAPY OVERALL MARKET SIZE

2.1 Global Longevity and Anti-senescence Therapy Market Size: 2021 VS 2028
2.2 Global Longevity and Anti-senescence Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Longevity and Anti-senescence Therapy Players in Global Market
3.2 Top Global Longevity and Anti-senescence Therapy Companies Ranked by Revenue
3.3 Global Longevity and Anti-senescence Therapy Revenue by Companies
3.4 Top 3 and Top 5 Longevity and Anti-senescence Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Longevity and Anti-senescence Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Longevity and Anti-senescence Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Longevity and Anti-senescence Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Longevity and Anti-senescence Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Longevity and Anti-senescence Therapy Market Size Markets, 2021 & 2028
  4.1.2 Hemolytic Drug Therapy
  4.1.3 Gene Therapy
  4.1.4 Immunotherapy
  4.1.5 Other Stem Cell Therapies
4.2 By Type - Global Longevity and Anti-senescence Therapy Revenue & Forecasts
  4.2.1 By Type - Global Longevity and Anti-senescence Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Longevity and Anti-senescence Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Longevity and Anti-senescence Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Service Institution
  5.1.4 Drug and Device Sales
5.2 By Application - Global Longevity and Anti-senescence Therapy Revenue & Forecasts
  5.2.1 By Application - Global Longevity and Anti-senescence Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Longevity and Anti-senescence Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Longevity and Anti-senescence Therapy Market Size, 2021 & 2028
6.2 By Region - Global Longevity and Anti-senescence Therapy Revenue & Forecasts
  6.2.1 By Region - Global Longevity and Anti-senescence Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Longevity and Anti-senescence Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Longevity and Anti-senescence Therapy Revenue, 2017-2028
  6.3.2 US Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.3.3 Canada Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.3.4 Mexico Longevity and Anti-senescence Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Longevity and Anti-senescence Therapy Revenue, 2017-2028
  6.4.2 Germany Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.3 France Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.4 U.K. Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.5 Italy Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.6 Russia Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.4.8 Benelux Longevity and Anti-senescence Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Longevity and Anti-senescence Therapy Revenue, 2017-2028
  6.5.2 China Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.5.3 Japan Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.5.4 South Korea Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.5.6 India Longevity and Anti-senescence Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Longevity and Anti-senescence Therapy Revenue, 2017-2028
  6.6.2 Brazil Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.6.3 Argentina Longevity and Anti-senescence Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Longevity and Anti-senescence Therapy Revenue, 2017-2028
  6.7.2 Turkey Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.7.3 Israel Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Longevity and Anti-senescence Therapy Market Size, 2017-2028
  6.7.5 UAE Longevity and Anti-senescence Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 CohBar
  7.1.1 CohBar Corporate Summary
  7.1.2 CohBar Business Overview
  7.1.3 CohBar Longevity and Anti-senescence Therapy Major Product Offerings
  7.1.4 CohBar Longevity and Anti-senescence Therapy Revenue in Global Market (2017-2022)
  7.1.5 CohBar Key News
7.2 TA Sciences
  7.2.1 TA Sciences Corporate Summary
  7.2.2 TA Sciences Business Overview
  7.2.3 TA Sciences Longevity and Anti-senescence Therapy Major Product Offerings
  7.2.4 TA Sciences Longevity and Anti-senescence Therapy Revenue in Global Market (2017-2022)
  7.2.5 TA Sciences Key News
7.3 Unity Biotechnology
  7.3.1 Unity Biotechnology Corporate Summary
  7.3.2 Unity Biotechnology Business Overview
  7.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Major Product Offerings
  7.3.4 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue in Global Market (2017-2022)
  7.3.5 Unity Biotechnology Key News
7.4 AgeX Therapeutics?Inc
  7.4.1 AgeX Therapeutics?Inc Corporate Summary
  7.4.2 AgeX Therapeutics?Inc Business Overview
  7.4.3 AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Major Product Offerings
  7.4.4 AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Revenue in Global Market (2017-2022)
  7.4.5 AgeX Therapeutics?Inc Key News
7.5 PowerVision Inc.
  7.5.1 PowerVision Inc. Corporate Summary
  7.5.2 PowerVision Inc. Business Overview
  7.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Major Product Offerings
  7.5.4 PowerVision Inc. Longevity and Anti-senescence Therapy Revenue in Global Market (2017-2022)
  7.5.5 PowerVision Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Longevity and Anti-senescence Therapy Market Opportunities & Trends in Global Market
Table 2. Longevity and Anti-senescence Therapy Market Drivers in Global Market
Table 3. Longevity and Anti-senescence Therapy Market Restraints in Global Market
Table 4. Key Players of Longevity and Anti-senescence Therapy in Global Market
Table 5. Top Longevity and Anti-senescence Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Longevity and Anti-senescence Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Longevity and Anti-senescence Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Longevity and Anti-senescence Therapy Product Type
Table 9. List of Global Tier 1 Longevity and Anti-senescence Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Longevity and Anti-senescence Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Longevity and Anti-senescence Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Longevity and Anti-senescence Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Longevity and Anti-senescence Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Longevity and Anti-senescence Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Longevity and Anti-senescence Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Longevity and Anti-senescence Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2023-2028
Table 30. CohBar Corporate Summary
Table 31. CohBar Longevity and Anti-senescence Therapy Product Offerings
Table 32. CohBar Longevity and Anti-senescence Therapy Revenue (US$, Mn), (2017-2022)
Table 33. TA Sciences Corporate Summary
Table 34. TA Sciences Longevity and Anti-senescence Therapy Product Offerings
Table 35. TA Sciences Longevity and Anti-senescence Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Unity Biotechnology Corporate Summary
Table 37. Unity Biotechnology Longevity and Anti-senescence Therapy Product Offerings
Table 38. Unity Biotechnology Longevity and Anti-senescence Therapy Revenue (US$, Mn), (2017-2022)
Table 39. AgeX Therapeutics?Inc Corporate Summary
Table 40. AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Product Offerings
Table 41. AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Revenue (US$, Mn), (2017-2022)
Table 42. PowerVision Inc. Corporate Summary
Table 43. PowerVision Inc. Longevity and Anti-senescence Therapy Product Offerings
Table 44. PowerVision Inc. Longevity and Anti-senescence Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Longevity and Anti-senescence Therapy Segment by Type in 2021
Figure 2. Longevity and Anti-senescence Therapy Segment by Application in 2021
Figure 3. Global Longevity and Anti-senescence Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Longevity and Anti-senescence Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Longevity and Anti-senescence Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Longevity and Anti-senescence Therapy Revenue in 2021
Figure 8. By Type - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 12. US Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 24. China Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Longevity and Anti-senescence Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Longevity and Anti-senescence Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. CohBar Longevity and Anti-senescence Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. TA Sciences Longevity and Anti-senescence Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Unity Biotechnology Longevity and Anti-senescence Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PowerVision Inc. Longevity and Anti-senescence Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)